UY29794A1 - SULFONAMIDE COMPOUNDS, PROCESSES AND INTERMEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS - Google Patents

SULFONAMIDE COMPOUNDS, PROCESSES AND INTERMEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS

Info

Publication number
UY29794A1
UY29794A1 UY29794A UY29794A UY29794A1 UY 29794 A1 UY29794 A1 UY 29794A1 UY 29794 A UY29794 A UY 29794A UY 29794 A UY29794 A UY 29794A UY 29794 A1 UY29794 A1 UY 29794A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
intermediaries
compositions containing
applications
processes
Prior art date
Application number
UY29794A
Other languages
Spanish (es)
Inventor
Nicholas Kindon
Mete Antonio
Teobald Barry
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37889110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29794(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY29794A1 publication Critical patent/UY29794A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C07D241/22—Benzenesulfonamido pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

La invención proporciona un compuesto de fórmula (1), en donde R1, R2 y R3 son como se define en la memoria descriptiva, composiciones farmacéuticas que los contiene, un proceso para preparar las composiciones farmacéuticas y su uso en terapia.The invention provides a compound of formula (1), wherein R1, R2 and R3 are as defined in the specification, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions and their use in therapy.

UY29794A 2005-09-19 2006-09-15 SULFONAMIDE COMPOUNDS, PROCESSES AND INTERMEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS UY29794A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0502068 2005-09-19

Publications (1)

Publication Number Publication Date
UY29794A1 true UY29794A1 (en) 2007-04-30

Family

ID=37889110

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29794A UY29794A1 (en) 2005-09-19 2006-09-15 SULFONAMIDE COMPOUNDS, PROCESSES AND INTERMEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS

Country Status (4)

Country Link
AR (1) AR056522A1 (en)
TW (1) TW200800921A (en)
UY (1) UY29794A1 (en)
WO (1) WO2007035154A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI328007B (en) 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
JP5406039B2 (en) 2006-12-21 2014-02-05 バーテックス ファーマシューティカルズ インコーポレイテッド 5-Cyano-4- (pyrrolo [2,3B] pyridin-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60207890T2 (en) * 2001-12-18 2006-08-10 Astrazeneca Ab NEW CONNECTIONS
TWI328007B (en) * 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
US20060004010A1 (en) * 2002-07-10 2006-01-05 Hiromu Habashita Ccr4 antagonist and medical use thereof
SE0301653D0 (en) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
TW200800921A (en) 2008-01-01
WO2007035154A1 (en) 2007-03-29
AR056522A1 (en) 2007-10-10

Similar Documents

Publication Publication Date Title
UY30976A1 (en) NEW DERIVATIVES OF QUINOLINA, PHARMACCUTIC COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS.
UY29795A1 (en) ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY29767A1 (en) BENZOTIAZOLONAS DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
UY28572A1 (en) NEW COMPOUNDS
UY31524A1 (en) NEW COMPOUNDS 010
UY29234A1 (en) ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS.
UY31481A1 (en) NEW PIRIMIDINE DERIVATIVES, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
UY28946A1 (en) ARIL-Y HETEROARIL-ALQUILANINA COMPOUNDS CONTAINING PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS AND NEW INTERMEDIATE CHEMICALS
UY28342A1 (en) NEW COMPOUNDS
UY29370A1 (en) DERIVATIVES OF TIAZOL, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURES AND APPLICATIONS
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
UY29002A1 (en) NEW HIDANTOINE DERIVATIVES, PARASU PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
ECSP077271A (en) PIRIMIDINE DERIVATIVES
UY30195A1 (en) DERIVATIVES OF PHENETANOLAMINE, PREPARATION PROCEDURE, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
ECSP077259A (en) PIRIMIDINE DERIVATIVES
UY28800A1 (en) 5,6-DIALQUIL-7-AMINO-TRIAZOLOPIRIMIDINAS, PROCEDURES FOR THEIR PREPARATION AND THE USE OF THEM TO COMBAT HARMFUL FUNGI
UY29003A1 (en) NEW HIDANTOINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THERAPY
UY30808A1 (en) BENZOTIAZOLONAS DERIVATIVES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
UY30748A1 (en) NEW COMPOUNDS
UY30206A1 (en) DIAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
ECSP11011439A (en) SUBSTITUTED 1-CYANOETHYLETHYCLIC CARBOXAMIDE 750 COMPOUNDS
UY27516A1 (en) BENCIMIDAZOLS
UY29607A1 (en) CHEMICAL COMPOUNDS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160926